The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...

Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...

A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a ...

A revolutionary pacemaker that re-establishes the heart's naturally irregular beat is set to be trialled in New Zealand heart patients this year. A revolutionary pacemaker that re-establishes the ...

A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be trialled in New Zealand heart patients this year, following successful animal trials. “Currently, all ...

The Implantable Cardiac Pacemaker Market is estimated to be valued at US$4.51 billion in 2022 and is expected to exhibit a CAGR of 3.6% over the forecast period from 2023 to 2030, as highlighted in a ...

A pacemaker is a small, battery-powered device that controls the heartbeat. Our heartbeats are controlled by a highly efficient, biological electrical system that ensures our heart steadily pumps ...

The thin, flexible, lightweight device could be used in patients who need temporary pacing after cardiac surgery or while waiting for a permanent pacemaker. All components of the pacemaker are ...

Heart problems are nothing new. Humans have been fascinated by electrocardiography since the era of Hippocrates (via St. Luke's Hospital Cardiology Department). With each passing century, medicine's ...